UNAIR Inactivated COVID-19 Vaccine Phase III (Immunobridging Study)

Clinical trial NCT05508477 · UNKNOWN

Trial details

NCT number: NCT05508477
Sponsor: Dr. Soetomo General Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Pandemic COVID-19 Vaccines

Start date: 2022-06-28
Primary completion: 2023-03-28
Enrollment: 4005

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.